Marie‐Claude Hofmann
The University of Texas MD Anderson Cancer Center
ORCID: 0000-0002-4899-8039Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 8 papers. Top paper: “Fibronectin Contributes to a BRAF Inhibitor–driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2”.
Nikita Pozdeyev, Sharon B. Sams, Umarani Pugazhenthi, Elise S. Bales, Marie‐Claude Hofmann +3 more
Elena McBeath, Marie‐Claude Hofmann
Therapeutic Potential of Ralimetinib, a p38/MAPK14 Inhibitor, in Anaplastic Thyroid Cancer
Ali Dadbin, Ying C. Henderson, Elena McBeath Fujiwara, Clifford Stephan, Roza Nurieca +8 more
Veronica L. Espinoza, Katelyn J. Hoff, Laura A. Pike, Vibha Sharma, Marie‐Claude Hofmann +4 more
Keigi Fujiwara, Marie‐Claude Hofmann, Elena McBeath
Gabriel M. Pagnotti, Joseph L. Kidd, David L. Ramírez, Trupti Trivedi, Leah Gandee +13 more
Jan Parker‐Thornburg, Yuka Fujii, Neeraj K. Aryal, Chad Smith, Marie‐Claude Hofmann +3 more
Rozita Bagheri‐Yarmand, Muthusamy Kunnimalaiyaan, Paola Miranda Mendez, Joseph L. Kidd, Ali Dadbin +18 more